Shanghai Virogin Biotech Co., Ltd.
Shanghai Virogin Biotech Co., Ltd.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With Solid Tumors | Advanced Malignant Solid Tumor | Recruiting | Phase 1 | 2026-03-25 | NCT07262164 | |
| A Study of AK112 in Combination With VG2025 in Colorectal Cancer With Liver Metastases | Colorectal Cancer With Hepatic Metastases | Not yet recruiting | Phase 1 / Phase 2 | 2026-01-21 | NCT07357220 | |
| A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2025 in Patients with Solid Tumors | Advanced Malignant Solid Tumor | Recruiting | Phase 1 | 2025-04-01 | NCT05477849 |